General Information
| Application | Inhibitor |
|---|
| Description | LY2857785 is a type I reversible and competitive ATP kinase inhibitor against CDK9 (IC50=0.011 μM) and also inhibits other transcription kinases CDK8 (IC50=0.016 μM) and CDK7 (IC50=0.246 μM). |
|---|
| Cas NO. | 1619903-54-6 |
|---|
| Purity | ≥98% |
|---|---|
| Molecular Weight | 448.60 |
| Formula | C26H36N6O |
| Solubility |
DMSO : 23 mg/mL Ethanol : 42 mg/mL Water : Insoluble |
|---|
| Alias | N/A |
|---|
| Target / IC50 |
CDK7 : 0.246 μM CDK8 : 0.016 μM CDK9 : 0.011 μM |
|---|
| Storage |
Powder : -20°C for 3 years |
|---|
|
|
1 mg |
5 mg |
10 mg |
|
|
1 mM |
2.2292 mL | 11.1458 mL | 22.2916 mL | |
| 5 mM | 0.44589 mL | 2.2292 mL | 4.4583 mL | |
| 10 mM | 0.2229 mL | 1.1146 mL | 2.2292 mL | |
.png)